Microbial Colonization of Oral Probiotics

NCT05375383 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2022-05-16

No results posted yet for this study

Summary

The aim of this study is to evaluate the colonization efficacy of probiotic lozenges and powders containing specific prebiotics in healthy adults

Conditions

  • Microbial Colonization

Interventions

DIETARY_SUPPLEMENT

Streptococcus salivarius K12 lozenge

In this study, a lozenge will be evaluated for its potential of delivering probiotic Streptococcus salivarius K12 to the oral cavity.

DIETARY_SUPPLEMENT

Probiotic S. salivarius K12 lozenges containing prebiotic A

In this study, a lozenge containing a prebiotic will be evaluated for its potential of delivering probiotic Streptococcus salivarius K12 to the oral cavity.

DIETARY_SUPPLEMENT

Probiotic S. salivarius K12 lozenges containing prebiotic B

In this study, a lozenge containing a prebiotic will be evaluated for its potential of delivering probiotic Streptococcus salivarius K12 to the oral cavity.

DIETARY_SUPPLEMENT

Probiotic S. salivarius K12 lozenges containing prebiotics A and B

In this study, a lozenge containing two prebiotics will be evaluated for its potential of delivering probiotic Streptococcus salivarius K12 to the oral cavity.

DIETARY_SUPPLEMENT

Probiotic S. salivarius K12 powder

In this study, a powder will be evaluated for its potential of delivering probiotic Streptococcus salivarius K12 to the oral cavity

DIETARY_SUPPLEMENT

Probiotic S. salivarius K12 powder containing prebiotic A

In this study, a powder containing a prebiotic will be evaluated for its potential of delivering probiotic Streptococcus salivarius K12 to the oral cavity

DIETARY_SUPPLEMENT

Probiotic S. salivarius K12 powder containing prebiotic B

In this study, a powder containing a prebiotic will be evaluated for its potential of delivering probiotic Streptococcus salivarius K12 to the oral cavity

DIETARY_SUPPLEMENT

Probiotic S. salivarius K12 powder containing prebiotics A and B

In this study, a powder containing two prebiotics will be evaluated for its potential of delivering probiotic Streptococcus salivarius K12 to the oral cavity

DIETARY_SUPPLEMENT

Probiotic S. salivarius M18 lozenges

In this study, a lozenge containing will be evaluated for its potential of delivering probiotic Streptococcus salivarius M18 to the oral cavity.

DIETARY_SUPPLEMENT

Probiotic S. salivarius M18 lozenges containing prebiotic A

In this study, a lozenge containing a prebiotic will be evaluated for its potential of delivering probiotic Streptococcus salivarius M18 to the oral cavity.

DIETARY_SUPPLEMENT

Probiotic S. salivarius M18 lozenges containing prebiotic B

In this study, a lozenge containing a prebiotic will be evaluated for its potential of delivering probiotic Streptococcus salivarius M18 to the oral cavity.

DIETARY_SUPPLEMENT

Probiotic S. salivarius M18 + lozenges containing prebiotic A and B

In this study, a lozenge containing two prebiotics will be evaluated for its potential of delivering probiotic Streptococcus salivarius M18 to the oral cavity.

Sponsors & Collaborators

  • BLIS Technologies Limited

    lead INDUSTRY

Principal Investigators

  • John D Hale, PhD · Blis Technologies Ltd

  • Rohit Jain, PhD · Blis Technologies Ltd, Dunedin, New Zealand

  • John R Tagg, PhD · Blis Technologies Ltd, Dunedin, New Zealand

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-06-15
Primary Completion
2022-08-31
Completion
2022-09-15

Countries

  • New Zealand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05375383 on ClinicalTrials.gov